20% off all books with the code: BOOKS
  • check 10+ million books
  • check New arrivals every day
  • check Trusted by 1M+ customers
  • check Great prices & discounts
  • check Shipping across Europe

Racivir: Nucleoside Reverse Transcriptase Inhibitor, Reverse Transcriptase -

English
2026-03-20
€179.62 €224.53

-20% with code BOOKS

In stock at our supplier

Shipping in 15-21 days

30-day return policy

High Quality Content by WIKIPEDIA articles! Racivir is an experimental nucleoside reverse transcriptase inhibitor (NRTI), developed by Pharmasset for the treatment of HIV. Reverse transcriptase inhibitors (RTIs) are a class of antiretroviral drug used to treat HIV infection, tumors, and cancer. RTIs inhibit activity of reverse transcriptase, a viral DNA polymerase enzyme that retroviruses need to reproduce. ... Full description

You May Also Like

Description

High Quality Content by WIKIPEDIA articles! Racivir is an experimental nucleoside reverse transcriptase inhibitor (NRTI), developed by Pharmasset for the treatment of HIV. Reverse transcriptase inhibitors (RTIs) are a class of antiretroviral drug used to treat HIV infection, tumors, and cancer. RTIs inhibit activity of reverse transcriptase, a viral DNA polymerase enzyme that retroviruses need to reproduce. When HIV infects a cell, reverse transcriptase copies the viral single stranded RNA genome into a double-stranded viral DNA. The viral DNA is then integrated into the host chromosomal DNA, which then allows host cellular processes, such as transcription and translation to reproduce the virus. RTIs block reverse transcriptase's enzymatic function and prevent completion of synthesis of the double-stranded viral DNA, thus preventing HIV from multiplying.

More Information

Publisher OmniScriptum
Release year 2026
Cover type Softcover
EAN 9786131185038
Write Your Own Review
You're reviewing: Racivir: Nucleoside Reverse Transcriptase Inhibitor, Reverse Transcriptase
Your Rating:

Goodreads Reviews

€179.62 €224.53